1. Home
  2. VRAX vs XTKG Comparison

VRAX vs XTKG Comparison

Compare VRAX & XTKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • XTKG
  • Stock Information
  • Founded
  • VRAX 2013
  • XTKG 1997
  • Country
  • VRAX United Kingdom
  • XTKG Singapore
  • Employees
  • VRAX N/A
  • XTKG N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • XTKG
  • Sector
  • VRAX Health Care
  • XTKG
  • Exchange
  • VRAX Nasdaq
  • XTKG NYSE
  • Market Cap
  • VRAX 7.3M
  • XTKG 8.5M
  • IPO Year
  • VRAX 2022
  • XTKG 2019
  • Fundamental
  • Price
  • VRAX $1.87
  • XTKG $0.61
  • Analyst Decision
  • VRAX
  • XTKG
  • Analyst Count
  • VRAX 0
  • XTKG 0
  • Target Price
  • VRAX N/A
  • XTKG N/A
  • AVG Volume (30 Days)
  • VRAX 304.3K
  • XTKG 102.4K
  • Earning Date
  • VRAX 02-05-2025
  • XTKG 11-27-2024
  • Dividend Yield
  • VRAX N/A
  • XTKG N/A
  • EPS Growth
  • VRAX N/A
  • XTKG N/A
  • EPS
  • VRAX N/A
  • XTKG N/A
  • Revenue
  • VRAX $84,872.00
  • XTKG $15,234,138.00
  • Revenue This Year
  • VRAX $5,169.18
  • XTKG N/A
  • Revenue Next Year
  • VRAX $66.97
  • XTKG N/A
  • P/E Ratio
  • VRAX N/A
  • XTKG N/A
  • Revenue Growth
  • VRAX 7.03
  • XTKG 51.59
  • 52 Week Low
  • VRAX $0.60
  • XTKG $0.08
  • 52 Week High
  • VRAX $9.00
  • XTKG $2.14
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 48.66
  • XTKG 37.62
  • Support Level
  • VRAX $1.65
  • XTKG $0.56
  • Resistance Level
  • VRAX $2.10
  • XTKG $0.68
  • Average True Range (ATR)
  • VRAX 0.22
  • XTKG 0.10
  • MACD
  • VRAX 0.01
  • XTKG -0.01
  • Stochastic Oscillator
  • VRAX 42.47
  • XTKG 10.95

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About XTKG X3 HOLDINGS CO LTD

X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries that operates across four business segments: digital technologies, renewable energy, Cryptomining Operations, and agriculture technologies.

Share on Social Networks: